The FDA confirmed the nationwide shortage of sodium chloride 0.9% injection, or IV saline, has officially ended.
The IV saline shortage, which has affected hospitals and clinics across the country, is no longer listed in the FDA’s Drug Shortage Database, according to an Aug. 8 statement from agency Commissioner Marty Makary, MD. The FDA credited increased manufacturing capacity and temporary importation efforts for stabilizing supply.
In addition, to help address the shortage, Dr. Makary said the agency worked alongside the Administration for Strategic Preparedness and Response and other industry manufacturers to restore supply levels. While the sodium chloride 0.9% injection is considered stable, the agency noted in the statement that other IV solutions remain in short supply.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
